Corticosteroids

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/76

encourage image

There's no tags or description

Looks like no tags are added yet.

77 Terms

1
New cards

two groups of corticosteroids

glucocorticoids

mineralocorticoids

2
New cards

synthetic glucocorticoids

dexamethasone

betamethasone

triamcinolone

methylprednisolone

hydrocortisone (cortisol)

cortisone

budesonide

beclomethasone

fludrocortisone

3
New cards

natural glucocorticoids - hippocampus pathway

hippocampus triggers hypothalamus to release CRH → pituitary release ACTH → release cortisol from adrenal

4
New cards

clinical uses of synthetic GCs

adrenal insufficiencies

inflammatory conditions

autoimmune diseases

allergic conditions

chronic respiratory illness

infectious diseases

blood malignancies

severe injury

organ transplantation

5
New cards

properties of GCs

inhibitory effects on inflammatory cytokines (interleukins IL-1,2,6) and TNFa

inhibits leukocyte recruitment and immune response

block inflammatory arachidonic acid pathway

6
New cards

GC genomic vs non genomic actions

genomic: GC → GR through transcription→ pharmacological action

non-genomic: → stress kinases through signal transduction → pharmacological action

7
New cards

GC mediated effects are through their receptors belonging to

nuclear receptor family

  • GR alpha is the active form with 777 aa at C-term

  • GR B is truncated dominant negative mutant isoform, lacks 35 aa in C-term which lacks normal transcription fx


8
New cards

GR, MR, PR, AR, ER has what dimerization property

homodimerism

9
New cards

TR has what dimerization property

heterodimerization

10
New cards

GC MOI

glucocorticoid diffusion through simple diffusion

bind to GR receptor and GR forms homodimer

chaperone protein release GR homodimer from cytosol to enter nucleus to enhance or repress gene transcription

11
New cards

what is the chaperone in the GC action

Hsp70/90 (heat shock protein)

12
New cards

glucocorticoids on arachidonic acid pathway

inhibits phospholipase A2 to inhibit production of arachidonic acid

  • this in turn decreases leukotrienes since there is no AA made, so it decreases asthma attacks


13
New cards

cyclooxygenase gets inhibited by

NSAIDs

14
New cards

GC turns on what gene to inhibit phospholipase A2

annexin 1 (lipocortin1) gets turned on to inhibit phospholipase A2

15
New cards

what is GILZ

glucocorticoid induced leucine zipper, GC activates GILZ to inhibit COX2, which decreases inflammatory pathway

  • decreases prostaglandin synthesis


16
New cards

corticosteroid suppression of activated inflammatory genes

interleukin 1B

granulocyte macrophage

colony stimulating factor

interleukin 6

interleukin 8

interferon y

and inducible NO synthase

17
New cards

NF-kB

inflammatory stimuli turns on transcription of NF-kB and as a result inflammatory genes and their respective proteins

18
New cards

how do GCs suppress the NF-kB target genes

GCs use GR to suppress the NF-kB target genes, competes with NF-kB

19
New cards

what are the potent anti-inflammatory drugs with longer plasma half life and the least mineralocorticoid action

dexamethasone and bethamethasone

  • decrease MR mediated side effects because 0 affinity to MR

more specific to GR which makes them high affinity binders for GR

20
New cards

dexamethasone has what biological half life (how long it remains in tissue)

36-54 hours

highest half life for GCs

21
New cards

what is dexamethasone plasma half life (time it stays in the plasma)

100-300 minutes

22
New cards

what is the most potent GC

dexamethasone

23
New cards

when is dexamethasone used

septic shock

brain edema

24
New cards

therapeutic effects of GC

decrease pain, stiffness, swelling, physical disability

anti-allergic

25
New cards

adverse effects of GCs

increase cardiovascular risk

cause cataracts (children at risk, prednisone of 10-15 mg/day or greater should receive periodic slit lamp exam), glaucoma

gastric ulcer if with NSAIDs

weight gain

increases susceptibility to infections by weakening immune system

myopathy

osteoporosis

neuro-psychiatric symptoms

26
New cards

specific AE of corticosteroids

cushing’s syndrome: with irregular fat distribution, moon face, purple striae, ecchymosis

fluid and electrolyte abnormalities, HTN, hypokalemic alkalosis - non specific MR effects

hyperglycemia: metabolic effects on liver and pancreas

osteoporosis due to decreased Ca absorption, inhibits osteoblast formation

myopathy: weakness of limb muscles due to proteolysis, chronic asthma of COPD pts resp muscles can be affected

immune effects: increase susceptibility to bacterial, fungal, viral infections

27
New cards

GC regulates hyperglycemia by

inhibiting insulin secretion from pancreas

promotes glucose production from the liver (gluconeogenesis → gluconeogenesis genes will increase)

decreases glucose uptake from skeletal muscle and adipose tissue

28
New cards

GC contraindication/management with DM patients

DM pt that is borderline hyperglycemic

  • would need to increase dose of anti-DM drug (insulin) to manage hyperglycemia in order to give GC (since GC increases hyperglycemia)


29
New cards

GCs possessing MR stimulating activity (non specific GCs)

hydrocortisone

prednisolone

prednisone

30
New cards

what is the effect of GC acting on MR

stimulates Na retention, bypassing renin-angiotensin path (RAAS) which results in HTN

31
New cards

how to manage HTN in pts that need to take chronic GC

spironolactone - MR antagonist to decrease HTN result

32
New cards

osteoporosis toxic effect of GC

diminished GI absorption of Ca both via

  • inhibition of vitamin D action

  • inhibition of intestinal calcium channel expression followed by suppression on osteoblasts

  • promotion of bone resorption by osteoclasts

  • calcium 1200mg/day and vit D 800/day supplements

osteonecrosis: cell death in bone, femoral head region common (use joint replacement)

33
New cards

retardation of growth and development with GC toxic effects

during fetal development stage, exposure could impair proper development

pregnant pts should not be administered GCs because it could impact kids adrenal insufficiency

34
New cards

withdrawal of GC therapy

underlying disease flares up

gradual tapering of daily dose or transition to alternate day regimen with gradual dose reduction

withdrawal syndrome: fever, myalgia, arthralgias, malaise

if signs of acute adrenal insufficiency (low BP, weakness, fatigue), immediate return to higher dose is warranted

35
New cards

rare and serious adverse effect of GCs

pseudotumor cerebri

36
New cards

what is pseudotumor cerebri

increased intracranial pressure with papilledema - with sudden reduction or withdrawal of GC therapy

37
New cards

papilledema

bulging optic disk and increased intracranial pressure

38
New cards

Drug interactions of GCs - do not take with

non specific GCs aggravate hypokalemia (reduced potassium) do not give with:

  • potassium agents (amphotericin B -anti fungal)

  • diuretics (loop and thiazide diuretics)

when used with anti DM meds, adjust antidiabetic drug (increase) with admin of GC and monitor blood glucose

increased risk of GI bleeding with NSAIDs

39
New cards

contraindication of GCs

only given for life saving conditions in DM pts

do not use as anti-inflammatory in immunocompromised or pts suffering from long term bacterial/viral/fungal infections

40
New cards

inhaled GCs

fluticasone

budesonide

ciclesonide

mometasone

flunisolide

41
New cards

inhaled GCs characteristics

higher receptor affinity for GR

gets accumulated in nasal epithelial cells

rate or frequency of cellular efflux is low - (cell efflux = cells try to kick drug out of body)

42
New cards

adverse effects with inhaled GCs

oropharyngeal candidiasis

osteoporosis

ophthalmic complications:

  • cataracts

  • glaucoma

  • dry eye disease


43
New cards

what synthesizes and secretes CRH

the paraventricular nucleus of the hypothalamus

44
New cards

what type of feedback loop does the hypothalamic pituitary axis

negative feedback loop

45
New cards

ACTH activates

zona fasciculata to secrete cortisol (GC)

determined by the brain

46
New cards

renin angiotensin activates

zona glomerulosa to release aldosterone (MC)

determined by kidney

47
New cards

what is the endogenously secreted glucocorticoid

cortisol

synthesized by cholesterol - pregnenolone pathway

site of synthesis is zona fasciculata

48
New cards

enzymes required for cortisol synthesis

steroid hydroxylases - present in zona fasciculata

49
New cards

metabolism of cortisol

plasma half life is 60-120

metabolism includes reduction following conjugation involving glucuronidation (soluble)

50
New cards

active and inactive form of cortisol

active: cortisol - mostly present in liver (liver has more 11B HSD1 makes active form)

inactive: cortisone - mostly in kidneys (11B HSD2)

11B HSD → hydroxysteroid dehydrogenase

51
New cards

physiological actions of cortisol

increases blood glucose by promoting gluconeogenesis

increase muscle protein catabolism to promote lipolysis from adipose

stress response

potent endogenous anti-inflammatory

immunosuppressant

52
New cards

disease affecting corticosteroid secretion

addison’s disease

cushing’s syndrome

cushing’s disease

53
New cards

addison’s disease with corticosteroid secretion

corticosteroid insufficiency due to T cell mediated autoimmune rx leading to adrenal cortex destruction

  • can also result due to malfunctioning HPA axis including tumors


54
New cards

cushing’s syndrome with corticosteroid secretion

glucocorticoid excess due to pituitary or adrenal tumors

excess chronic endogenous GC release (hyperactivation of HPA axis) or synthetic GC use/admin

55
New cards

cushing’s disease with corticosteroid secretion

umbrella of Cushing’s syndrome caused due to benign pituitary adenoma

56
New cards

treatment for addison’s disease

hydrocortisone (cortef)

prednisone

cortisone acetate

oral or injections

57
New cards

addisonian crisis

addison’s disease if untreated undergo infection, injury or surgery

low blood glucose, low BP due to hyponatremia and hyperkalemia

58
New cards

treatment of addisonian crisis

hydrocortisone along with saline and dextrose

59
New cards

adrenal insufficiency

addison’s disease is a type 1 or primary AI

auto antibodies form against the steroid 21 hydroxylase enzyme in 90% of cases

  • can be caused by viral infections or chronic use of ketoconazole, phenytoin

stabilizing meds include glucocorticoid and mineralocorticoid replacement followed by isotonic saline and 5% dextrose administrations

60
New cards

regulators of ACTH to treat cushing’s syndrome

pasireotide (SIGNIFOR) activates SSTR to decrease ACTH

cabergoline (DOSTINEX) activates dopamine D2 receptor agonist, which decreases ACTH release

61
New cards

inhibitors of cortisol synthesis to treat cushing’s syndrome

ketoconazole, metyrapone, mitotane, etomidate

  • target 11 beta hydroxylase, reducing cortisol formation


62
New cards

GR blocking agent to treat cushing’s syndrome hyperglycemia

mifepristone used to regulate GC induced hyperglycemic complications and specific conditions

63
New cards

general mechanisms to treat cushing’s syndrome

regulators of ACTH

inhibitors of cortisol synthesis

GR blocking agent

64
New cards

diagnosis of cushing’s syndrome

dex suppression test

65
New cards

aldosterone is regulated by

kidney

site of synthesis is zona glomerulosa

66
New cards

RAAS major role is to

maintain sodium homeostasis

increases re-absorption of sodium in sweat glands, salivary glands and kidneys

activated due to decrease in arterial pressure, hyponatremia and hypovolemia

67
New cards

aldosterone physiological functions

increased expression in Na/K ATPase and ENaC channels

maintain sodium water balance

maintain normal arterial pressure

regulation of glomerular filtration rate - GFR

68
New cards

metabolism of MCs

transporters: transcortin and albumin

aldosterone has low affinity to binding these proteins

high hepatic first pass metabolism leads to 75% of oral drug getting excreted

69
New cards

mineralcorticoids MOA

ligand binds to MR in cytosol, HSP (chaperone) detach from MR

MR-aldosterone complex undergoes nuclear translocation and bind to responsive elements

70
New cards

fludrocortisone

synthetic mineralocorticoid prodrug available as fludrocortisone acetate

more MR affinity even tho it is a MC and GC

71
New cards

what is fludrocortisone used for

addison’s disease

postural orthostatic tachycardia syndrome

adrenogenital syndrome

72
New cards

adverse effects of fludrocortisone excess

hypokalemia and cardiac fibrosis

73
New cards

conn’s syndrome

primary aldosteronism

HTN and hypokalemia

sx: HA, muscle cramps, excessive thirst

insulin resistance, DM, liver fibrosis, osteoporosis, hyperparathyroidism, depression/anxiety, disturbances of calcium and collagen metabolism

74
New cards

serious complications of conn’s syndrome

atrial fibrillation

MI

HF

stroke

kidney failure

75
New cards

primary aldosteronism occurs in the absence of

absence of renin-angiotensin activation

increased aldosterone in absence of RAAS

76
New cards

treatment of primary aldosteronism

spironolactone (non specific to MR), eplerenone (specific to MR)

  • MR receptor antagonists

2nd line is adrenalectomy (removal of adrenal gland)

77
New cards

spironolactone is competitive or noncompetitive

competitive antagonist at MR and lacks specificity